Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Do Not Miss Karyotyping at Chronic Myeloid Leukemia Diagnosis: An Italian Campus CML Study on the Role of Complex Variant Translocations

Blood (2020) 136 (Supplement 1): 43–44.

https://doi.org/10.1182/blood-2020-139826

Published: 2020

Journal Articles

A Comparison of Droplet Digital PCR and RT-qPCR for BCR-ABL1 Monitoring in Chronic Myeloid Leukemia

Carmen Fava, Paola Berchialla, PhD, Jessica Petiti, PhD, Maria Teresa Bochicchio, Barbara Izzo, PhD, Emilia Giugliano, Emanuela Ottaviani, Santa Errichiello, PhD, Giovanna Rege Cambrin, MD PhD, Claudia Venturi, Luigiana Luciano, Filomena Daraio, Daniele Calistri, Alessandro Martino, Giuseppe Saglio, MD, Giovanni Martinelli, MD, Fabrizio Pane, MD, Daniela Cilloni, MD PhD, Enrico Marco Gottardi

Blood (2019) 134 (Supplement_1): 2092.

https://doi.org/10.1182/blood-2019-125614

Published: 2019

Journal Articles

Standardization of Two Dpcr Platforms for Detection of BCR/ABL1 - Minimal Residual Disease (MRD) in Ph+ Chronic Myeloid Leukemia (CML)

Carmen Fava, MD PhD, Simona Bernardi, PhD, Enrico Marco Gottardi, Dr., Filomena Daraio, PhD, Emilia Giugliano, Roberta Lorenzatti, Dr., Marta Varotto, Dr., Davide Barberio, Dr., Laura Galeotti, Francesco Ceccherini, Francesco Cordoni, Giovanna Rege-Carmbrin, Giuseppe Saglio, MD PhD, Domenico Russo, MD

Blood (2017) 130 (Supplement 1): 2867.

https://doi.org/10.1182/blood.V130.Suppl_1.2867.2867

Published: 2017

Journal Articles

A New Sensitive and Fast Molecular Analysis Method for the Identification of 30 Different Markers in Acute Myeloid and Lymphoid Leukemias at Diagnosis Time

Emilia Giugliano, Roberta Lorenzatti, Dr., Enrico Marco Gottardi, Dr., Chiara Sammartino, Dr., Roberta Toja, Francesca Crasto, Dr, Alessandro Volpengo, Dr, Cristina Fantino, Dr, Filomena Daraio, PhD, Anna Serra, Dr, Francesca Carnuccio, Dr, Giuseppe Saglio, MD PhD, Angelo Guerrasio, MD

Blood (2017) 130 (Supplement 1): 5097.

https://doi.org/10.1182/blood.V130.Suppl_1.5097.5097

Published: 2017

Journal Articles

An Italian Multicentre Study Using Different Digital PCR Instruments on BCR-ABL1 Positive Patients at Different Levels of CML Disease

Filomena Daraio, PhD, Emilia Giugliano, Carmen Fava, MD PhD, Roberta Lorenzatti, Dr., Marta Varotto, Dr., Davide Barberio, Dr., Simona Bernardi, PhD, Barbara Izzo, PhD, Santa Errichiello, PhD, Maria Teresa Bochicchio, Claudia Venturi, Dr., Francesco Albano, MD, Giuseppe Saglio, MD PhD, Fabrizio Pane, MD, Giovanni Martinelli, MD, Giorgina Specchia, MD, Domenico Russo, MD, Enrico Marco Gottardi, Dr.

Blood (2017) 130 (Supplement 1): 4176.

https://doi.org/10.1182/blood.V130.Suppl_1.4176.4176

Published: 2017

Journal Articles

Morgana acts as an oncosuppressor in chronic myeloid leukemia

Blood (2015) 125 (14): 2245–2253.

https://doi.org/10.1182/blood-2014-05-575001

Published: 2015

Includes: Supplemental data

Journal Articles

Consistency Of RQ-PCR Analysis Results In Peripheral Blood and Bone Marrow Samples In Chronic Myeloid Leukemia Patients: Relevance From The Practical and Logistic Point Of View

Giovanna Rege-Cambrin, Carmen Fava, MD, Enrico Gottardi, BD, Filomena Daraio, PhD, Emilia Giugliano, PhD, Francesca Crasto, Roberta Lorenzatti, Alessandro Volpengo, Bruno Di Gioacchino, Giuseppe Saglio

Blood (2013) 122 (21): 2592.

https://doi.org/10.1182/blood.V122.21.2592.2592

Published: 2013

Journal Articles

Cytoplasmic-Nuclear Shuttling of mTOR Protein in Multiple Myeloma Cell Lines and Primary Myeloma Cells: A New Mechanism Regulated by Pomalidomide

Tommasina Guglielmelli, MD, Emilia Giugliano, PhD, Vanessa Brunetto, PhD, Sokol Rrodhe, MD, Giuseppe Saglio, MD

Blood (2012) 120 (21): 4019.

https://doi.org/10.1182/blood.V120.21.4019.4019

Published: 2012

Journal Articles

Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response: a study of the GIMEMA CML WP

Blood (2009) 114 (24): 4939–4943.

https://doi.org/10.1182/blood-2009-07-229864

Published: 2009

Includes: Supplemental data

Journal Articles

SIRT1 Activator 3 Potently Induces Apoptosis in Multiple Myeloma Cell Lines and in Primary Human Multiple Myeloma Cells.

Tommasina Guglielmelli, MD, Emilia Giugliano, PhD, Ilaria Defilippi, PhD, Marisa Pautasso, MD, Roberta Merlini, MD, Vanessa Brunetto, PhD, Giuseppe Saglio

Blood (2009) 114 (22): 3845.

https://doi.org/10.1182/blood.V114.22.3845.3845

Published: 2009

Journal Articles

The AKT/mTOR/P70S6K/4EB-P1 Signaling Pathway Is Activated in a Subset of Multiple Myeloma Patients and Correlates with High Serum Levels of Beta2-Microglobulin

Tommasina Guglielmelli, MD, Susanna Cappia, MD, Emilia Giugliano, PhD, Roberta Merlini, MD, Elisa Bacillo, MD, Francesca Gay, MD, Paola Berchialla, PhD, Dario Gregori, PhD, Mauro Papotti, PhD, Antonio Palumbo, MD, Giuseppe Saglio, PhD

Blood (2008) 112 (11): 2716.

https://doi.org/10.1182/blood.V112.11.2716.2716

Published: 2008

Journal Articles

Identification of the Involvement of the Tyrosine Kinase C-Ros in the Pathogenesis of Chronic Myelomonocytic Leukemia (CMML)

Daniela Cilloni, MD, PhD, Sonia Carturan, PhD, Enrico Bracco, PhD, Ilaria Defilippi, PhD, Chiara Maffè, PhD, Ilaria Iacobucci, Marisa Pautasso, MD, Antonia Rotolo, Emilia Giugliano, PhD, Emanuela Messa, MD, Giovanni Martinelli, MD, Giuseppe Saglio, MD

Blood (2008) 112 (11): 687.

https://doi.org/10.1182/blood.V112.11.687.687

Published: 2008

Journal Articles

Kinetics of Molecular Response to Imatinib in Chronic Myeloid Leukemia Patients May Predict Persistent Polymerase Chain Reaction Negativity after Imatinib Discontinuation.

Giovanna Rege-Cambrin, PhD, Stefano Ulisciani, MD, Giovanna Mattioli, MD, Carmen Fava, MD, Emilia Giugliano, BD, Vanessa Brunetto, BD, Enrico Gottardi, BD, Milena Fava, BD, Giuseppe Saglio, MD

Blood (2007) 110 (11): 1956.

https://doi.org/10.1182/blood.V110.11.1956.1956

Published: 2007

Journal Articles

Activation of the mTOR Signaling Pathway in Multiple Myeloma Patients and Its Prognostic Significance.

Tommasina Guglielmelli, MD, Susanna Cappia, MD, Emilia Giugliano, MD, Roberta Merlini, MD, Stefano Mussino, MD, Elena Bacillo, MD, Enrico Bracco, PhD, Maurizio Papotti, PhD, Giuseppe Saglio, PhD

Blood (2007) 110 (11): 1493.

https://doi.org/10.1182/blood.V110.11.1493.1493

Published: 2007

Journal Articles

Response to Imatinib or Imatinib Containing Regimens of Secondary Clones in Chronic Myeloid Leukemia Patients with Additional Chromosomal Abnormalities.

Debora Luzi, M.D., Lorenzo Falchi, M.D., Giovanna Rege Cambrin, M.D., Emilia Giugliano, Ph.D., Monica Schippa, M.D., Viola Festuccia, M.D., Ilaria Angeletti, M.D., Emilio Donti, M.D., Anna Marina Liberati, MD

Blood (2007) 110 (11): 4574.

https://doi.org/10.1182/blood.V110.11.4574.4574

Published: 2007

Journal Articles

Impact of Complete Kariotypic Remission (CKR) and Sokal Risk on Overall Survival in Chronic Myelogenous Leukemia (CML) Patients: A Monocentric Experience.

Lorenzo Falchi, Monica Schippa, Debora Luzi, Rita Emili, Viola Festuccia, Emilia Giugliano, Carmela Ardisia, Annamaria Rauco, Roberta Pace, Emilio Donti, Anna Marina Liberati

Blood (2006) 108 (11): 4803.

https://doi.org/10.1182/blood.V108.11.4803.4803

Published: 2006

Journal Articles

A Ph-Negative Myeloproliferative Disorder with JAK2 Mutation Disclosed by Imatinib Therapy in Two Patients with Ph+ CML.

Emilia Giugliano, BD, Dario Ferrero, MD, Carmen Fava, MD, Chiara Dellacasa, MD, Giovanna Mattioli, MD, Patrizia Scaravaglio, BD, Enrico Gottardi, Stefano Ulisciani, MD, Filomena Daraio, BD, Giuseppe Saglio, MD, Giovanna Rege-Cambrin, MD

Blood (2006) 108 (11): 4910.

https://doi.org/10.1182/blood.V108.11.4910.4910

Published: 2006

Journal Articles

Imatinib Mesylate Can Induce Molecular Complete Remission in Idiopathic Hypereosinophilic Syndrome (HES). A Phase II Multicentric Italian Clinical Trial.

Blood (2005) 106 (11): 375.

https://doi.org/10.1182/blood.V106.11.375.375

Published: 2005

Journal Articles

The Quantitative Assessment of WT1 Allows To Distinguish between Primary and Secondary or Reactive Hypereosinophilia.

Daniela Cilloni, MD, PhD, Francesca Messa, PhD, Giovanni Martinelli, MD, Enrico Gottardi, PhD, Ilaria Defilippi, PhD, Francesca Arruga, PhD, Sonia Carturan, PhD, Emanuela Messa, MD, Emilia Giugliano, PhD, Valentina Rosso, PhD, Serena Merante, MD, Annalisa Charenza, MD, Michela Rondoni, MD, Emanuela Ottaviani, PhD, Mario Tiribelli, MD, Fabrizio Pane, MD, Michele Baccarani, MD, Giuseppe Saglio, MD

Blood (2005) 106 (11): 3251.

https://doi.org/10.1182/blood.V106.11.3251.3251

Published: 2005

Journal Articles

Imatinib and pegylated human recombinant interferon-α2b in early chronic-phase chronic myeloid leukemia

Blood (2004) 104 (13): 4245–4251.

https://doi.org/10.1182/blood-2004-03-0826

Published: 2004

NARROW

Do Not Miss Karyotyping at Chronic Myeloid Leukemia Diagnosis: An Italian Campus CML Study on the Role of Complex Variant Translocations

A Comparison of Droplet Digital PCR and RT-qPCR for BCR-ABL1 Monitoring in Chronic Myeloid Leukemia

Standardization of Two Dpcr Platforms for Detection of BCR/ABL1 - Minimal Residual Disease (MRD) in Ph+ Chronic Myeloid Leukemia (CML)

A New Sensitive and Fast Molecular Analysis Method for the Identification of 30 Different Markers in Acute Myeloid and Lymphoid Leukemias at Diagnosis Time

An Italian Multicentre Study Using Different Digital PCR Instruments on BCR-ABL1 Positive Patients at Different Levels of CML Disease

Morgana acts as an oncosuppressor in chronic myeloid leukemia

Consistency Of RQ-PCR Analysis Results In Peripheral Blood and Bone Marrow Samples In Chronic Myeloid Leukemia Patients: Relevance From The Practical and Logistic Point Of View

Cytoplasmic-Nuclear Shuttling of mTOR Protein in Multiple Myeloma Cell Lines and Primary Myeloma Cells: A New Mechanism Regulated by Pomalidomide

Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response: a study of the GIMEMA CML WP

SIRT1 Activator 3 Potently Induces Apoptosis in Multiple Myeloma Cell Lines and in Primary Human Multiple Myeloma Cells.

The AKT/mTOR/P70S6K/4EB-P1 Signaling Pathway Is Activated in a Subset of Multiple Myeloma Patients and Correlates with High Serum Levels of Beta2-Microglobulin

Identification of the Involvement of the Tyrosine Kinase C-Ros in the Pathogenesis of Chronic Myelomonocytic Leukemia (CMML)

Kinetics of Molecular Response to Imatinib in Chronic Myeloid Leukemia Patients May Predict Persistent Polymerase Chain Reaction Negativity after Imatinib Discontinuation.

Activation of the mTOR Signaling Pathway in Multiple Myeloma Patients and Its Prognostic Significance.

Response to Imatinib or Imatinib Containing Regimens of Secondary Clones in Chronic Myeloid Leukemia Patients with Additional Chromosomal Abnormalities.

Impact of Complete Kariotypic Remission (CKR) and Sokal Risk on Overall Survival in Chronic Myelogenous Leukemia (CML) Patients: A Monocentric Experience.

A Ph-Negative Myeloproliferative Disorder with JAK2 Mutation Disclosed by Imatinib Therapy in Two Patients with Ph+ CML.

Imatinib Mesylate Can Induce Molecular Complete Remission in Idiopathic Hypereosinophilic Syndrome (HES). A Phase II Multicentric Italian Clinical Trial.

The Quantitative Assessment of WT1 Allows To Distinguish between Primary and Secondary or Reactive Hypereosinophilia.

Imatinib and pegylated human recombinant interferon-α2b in early chronic-phase chronic myeloid leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only